CorVel Corporation (CRVL) Stock Forecast and Price Target (2026)

Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. That is the situation with CRVL. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model rather than a consensus.

CorVel's fiscal year ends March 31, so the trailing figures run through the June 2026 quarter, with fiscal Q2 2027 due November 3, 2026. The trailing P/E near 36 is well above the ~28 the stock carried in mid-2026, after shares rose about 34% in three months on re-accelerating growth, though still below the premium it held through 2025. The 52-week range of roughly $45 to $83 shows how far sentiment has swung while earnings kept growing.

No analyst publishes estimates on CRVL, so these are the most recent figures we hold, as of October 2026. They describe where the company stands, not where it is going.

• Revenue (TTM to Jun 30, 2026): ~$984M; FQ1 2027 ~$260M (+11% YoY)
• Diluted EPS (TTM / FQ1 2027): ~$2.24 / $0.63 (+21% YoY)
• Net income (TTM): ~$115M; FQ1 2027 ~$32.2M (+18% YoY)
• Operating margin (TTM): ~16.7% (FY2026 ~14.9%)
• Cash and debt (Jun 30, 2026): ~$256M cash, no borrowings
• Market cap / trailing P/E: ~$4.1B / ~36x at $80.33 (Oct 16, 2026)

Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering CRVL do not put out a 2030 number. Anything presenting one is extrapolating a growth rate rather than reporting research, and a figure produced that way tells you about the assumption chosen, not about the company.

What can be said over a long horizon is what the current price already assumes about the business, which is a question the filings answer and a forecast cannot.

That is the more useful frame for a ten-year question. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether CorVel Corporation can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.

In short: the drivers cited most often are CERIS and commercial payment integrity, Bookings momentum and multiyear payer contracts, AI-driven margin expansion. The risk cited most often against it is the core end market is the central risk: workers' compensation claim frequency has trended down for years as workplaces automate and get safer, and soft premium rates squeeze what carriers and employers will pay for managed-care services.

Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the CRVL is it a buy page. This page deliberately stops at the numbers.